554 related articles for article (PubMed ID: 31696481)
21. MicroRNA-760 inhibits the biological progression of colorectal carcinoma by directly targeting FOXA1 and regulating epithelial-to-mesenchymal transition and PI3K/AKT signaling pathway.
Cong K; Li CG; Wei YH; Zhang K; Xu HB
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5730-5740. PubMed ID: 31298352
[TBL] [Abstract][Full Text] [Related]
22. MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3.
Fu S; Ma C; Tang X; Ma X; Jing G; Zhao N; Ran J
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34486645
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-489 targets XIAP to inhibit the biological progression of ovarian cancer via regulating PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition.
Jiang HW; Li L; Jiang P; Wang YF
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4113-4122. PubMed ID: 32373947
[TBL] [Abstract][Full Text] [Related]
24. Knockdown of circPUM1 impedes cell growth, metastasis and glycolysis of papillary thyroid cancer via enhancing MAPK1 expression by serving as the sponge of miR-21-5p.
Li Y; Qin J; He Z; Cui G; Zhang K; Wu B
Genes Genomics; 2021 Feb; 43(2):141-150. PubMed ID: 33481227
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
Li YM; Li XJ; Yang HL; Zhang YB; Li JC
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295
[TBL] [Abstract][Full Text] [Related]
26. MiR-4500 Regulates PLXNC1 and Inhibits Papillary Thyroid Cancer Progression.
Li R; Teng X; Zhu H; Han T; Liu Q
Horm Cancer; 2019 Dec; 10(4-6):150-160. PubMed ID: 31317324
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-203 restrains epithelial-mesenchymal transition, invasion and migration of papillary thyroid cancer by downregulating AKT3.
You A; Fu L; Li Y; Li X; You B
Cell Cycle; 2020 May; 19(10):1105-1121. PubMed ID: 32308106
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-517c Functions as a Tumor Suppressor in Hepatocellular Carcinoma via Downregulation of KPNA2 and Inhibition of PI3K/AKT Pathway.
Ma L; Tao C; Zhang Y
J Healthc Eng; 2022; 2022():7026174. PubMed ID: 35075389
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-149 suppresses the malignant phenotypes of ovarian cancer via downregulation of MSI2 and inhibition of PI3K/AKT pathway.
Zhao LW; Yu AJ; Zhang YJ; Wang XC; Han B; Wang XH
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):55-64. PubMed ID: 31957818
[TBL] [Abstract][Full Text] [Related]
30. MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1α-mediated VEGF signaling pathway.
Du Y; Zhu J; Chu BF; Yang YP; Zhang SL
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6570-6578. PubMed ID: 31378898
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer.
Gao H; Sun X; Wang H; Zheng Y
Cell Cycle; 2020 May; 19(10):1186-1199. PubMed ID: 32306838
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-520a-3p suppresses epithelial-mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1-mediated JAK/STAT signaling pathway.
Bi CL; Zhang YQ; Li B; Guo M; Fu YL
J Cell Physiol; 2019 Apr; 234(4):4054-4067. PubMed ID: 30206929
[TBL] [Abstract][Full Text] [Related]
33. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of NEAT1 reverses the radioactive iodine resistance of papillary thyroid carcinoma cell via miR-101-3p/FN1/PI3K-AKT signaling pathway.
Liu C; Feng Z; Chen T; Lv J; Liu P; Jia L; Zhu J; Chen F; Yang C; Deng Z
Cell Cycle; 2019 Jan; 18(2):167-203. PubMed ID: 30596336
[TBL] [Abstract][Full Text] [Related]
35. CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways.
Yu ST; Zhong Q; Chen RH; Han P; Li SB; Zhang H; Yuan L; Xia TL; Zeng MS; Huang XM
Cell Death Dis; 2018 Mar; 9(3):371. PubMed ID: 29515111
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.
Song HM; Luo Y; Li DF; Wei CK; Hua KY; Song JL; Xu H; Maskey N; Fang L
Int J Clin Exp Pathol; 2015; 8(9):9889-900. PubMed ID: 26617698
[TBL] [Abstract][Full Text] [Related]
37. Targeting EZH2 by microRNA-449a inhibits osteosarcoma cell proliferation, invasion and migration via regulation of PI3K/AKT signaling pathway and epithelial-mesenchymal transition.
Lu DG; Tang QL; Wei JH; He FY; Lu L; Tang YJ
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1656-1665. PubMed ID: 32141531
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-142-3P suppresses the progression of papillary thyroid carcinoma by targeting FN1 and inactivating FAK/ERK/PI3K signaling.
Jiang Y; Liu Y; Zhang Y; Ouyang J; Feng Y; Li S; Wang J; Zhang C; Tan L; Zhong J; Zou L
Cell Signal; 2023 Sep; 109():110792. PubMed ID: 37406787
[TBL] [Abstract][Full Text] [Related]
39. miR-200b/c-RAP1B axis represses tumorigenesis and malignant progression of papillary thyroid carcinoma through inhibiting the NF-κB/Twist1 pathway.
Zhou B; Xu J; Chen Y; Gao S; Feng X; Lu X
Exp Cell Res; 2020 Feb; 387(2):111785. PubMed ID: 31877303
[TBL] [Abstract][Full Text] [Related]
40. Silencing circRNA protein kinase C iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI/miR-335/E2F3 ceRNA axis.
Liu Y; Chen G; Wang B; Wu H; Zhang Y; Ye H
Endocr J; 2021 Jun; 68(6):713-727. PubMed ID: 33716239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
